PRF Technologies Ltd.
NASDAQ: PRFX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Efraim Cohen-Arazi
- Employees
- 2
- Headquarters
- Tel Aviv, Israel
- IPO year
- 2020
- Market cap
- $113.6K
- Website
- https://prf-tech.com
Loading PRFX…
Loading profile data…Frequently asked questions about PRFX
What does PRF Technologies Ltd. (PRFX) do?
PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct app...
Where does PRFX trade?
PRF Technologies Ltd. (PRFX) trades on the NASDAQ Capital Market.
What sector is PRFX in?
PRF Technologies Ltd. (PRFX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of PRF Technologies Ltd.?
Efraim Cohen-Arazi is the chief executive officer of PRF Technologies Ltd. (PRFX).
Where is PRF Technologies Ltd. headquartered?
PRF Technologies Ltd. is headquartered in Israel.
Does PRFX pay a dividend?
PRF Technologies Ltd. (PRFX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PRFX go public?
PRF Technologies Ltd. (PRFX) completed its initial public offering in 2020.